Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
High-performance liquid chromatography
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Legal === This technique is also used for detection of [[Prohibition of drugs|illicit drugs]] in various samples.<ref>{{Cite journal |last1=Merone |first1=Giuseppe M. |last2=Tartaglia |first2=Angela |last3=Rossi |first3=Sandra |last4=Santavenere |first4=Francesco |last5=Bassotti |first5=Elisa |last6=D'Ovidio |first6=Cristian |last7=Bonelli |first7=Martina |last8=Rosato |first8=Enrica |last9=de Grazia |first9=Ugo |last10=Locatelli |first10=Marcello |last11=Savini |first11=Fabio |date=2021 |title=Fast Quantitative LC-MS/MS Determination of Illicit Substances in Solid and Liquid Unknown Seized Samples |journal=Analytical Chemistry |language=en |volume=93 |issue=49 |pages=16308–16313 |doi=10.1021/acs.analchem.1c03310 |issn=0003-2700 |pmc=8674870 |pmid=34843645}}</ref> The most common method of drug detection has been an [[immunoassay]].<ref>{{Cite journal|title = An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients|url=http://www.painphysicianjournal.com/current/pdf?article=MTM1MQ%3D%3D&journal=55|journal = Pain Physician|date = 2010-06-01|pmid = 20495592|pages = 273–281|volume = 13|issue = 3|first1 = Amadeo|last1 = Pesce|first2 = Murray|last2 = Rosenthal|first3 = Robert|last3 = West|first4 = Cameron|last4 = West|first5 = Bridgit|last5 = Crews|first6 = Charles|last6 = Mikel|first7 = Perla|last7 = Almazan|first8 = Sergey|last8 = Latyshev}}</ref> This method is much more convenient. However, convenience comes at the cost of specificity and coverage of a wide range of drugs, therefore, HPLC has been used as well as an alternative method. As HPLC is a method of determining (and possibly increasing) purity, using HPLC alone in evaluating concentrations of drugs was somewhat insufficient. Therefore, HPLC in this context is often performed in conjunction with [[mass spectrometry]].<ref>{{Cite journal|title = Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry|journal = Journal of Analytical Toxicology|date = 2013-12-01|pmid = 24084874|pages = 642–651|volume = 37|issue = 9|doi = 10.1093/jat/bkt083|first1 = I.-Lin|last1 = Tsai|first2 = Te-I.|last2 = Weng|first3 = Yufeng J.|last3 = Tseng|first4 = Happy Kuy-Lok|last4 = Tan|first5 = Hsiao-Ju|last5 = Sun|first6 = Ching-Hua|last6 = Kuo|doi-access = free}}</ref> Using [[Liquid chromatography–mass spectrometry|liquid chromatography-mass spectrometry]] (LC-MS) instead of [[Gas chromatography–mass spectrometry|gas chromatography-mass spectrometry]] (GC-MS) circumvents the necessity for derivitizing with acetylating or alkylation agents, which can be a burdensome extra step.<ref>{{Cite journal|title = Automated solid-phase extraction and two-step derivatisation for simultaneous analysis of basic illicit drugs in serum by GC/MS|journal = International Journal of Legal Medicine|date = 2000-01-01|pmid = 10929239|pages = 229–235|volume = 113|issue = 4|first1 = W.|last1 = Weinmann|first2 = M.|last2 = Renz|first3 = S.|last3 = Vogt|first4 = S.|last4 = Pollak|doi=10.1007/s004149900098|s2cid = 20451772}}</ref> LC-MS has been used to detect a variety of agents like doping agents, drug metabolites, glucuronide conjugates, amphetamines, opioids, cocaine, BZDs, ketamine, LSD, cannabis, and pesticides.<ref>{{Cite journal|title = A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry|journal = Analytica Chimica Acta|date = 2007-02-28|pmid = 17386652|pages = 94–102|volume = 585|issue = 1|doi = 10.1016/j.aca.2006.12.028|first1 = Marjo|last1 = Kolmonen|first2 = Antti|last2 = Leinonen|first3 = Anna|last3 = Pelander|first4 = Ilkka|last4 = Ojanperä| bibcode=2007AcAC..585...94K }}</ref><ref>{{Cite journal|title = Toxicological screening with formula-based metabolite identification by liquid chromatography/time-of-flight mass spectrometry|journal = Analytical Chemistry|date = 2003-11-01|pmid = 14588010|pages = 5710–5718|volume = 75|issue = 21|doi = 10.1021/ac030162o|first1 = Anna|last1 = Pelander|first2 = Ilkka|last2 = Ojanperä|first3 = Suvi|last3 = Laks|first4 = Ilpo|last4 = Rasanen|first5 = Erkki|last5 = Vuori}}</ref> Performing HPLC in conjunction with mass spectrometry reduces the absolute need for standardizing HPLC experimental runs.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)